uniQure N.V. - Ordinary Shares —— 现金流量表 (NASDAQ:QURE) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -134.83 M287.96 M-145.06 M-145.93 M-182.73 M-177.96 M -172.11 M 投资活动产生的现金 -9.48 M-67.39 M-182.73 M-205.69 M162.97 M-321.62 M -243.16 M 融资活动产生的现金 7.44 M94.86 M1.45 M362.72 M-59.49 M415.4 M 335.28 M 自由现金流 -134.83 M287.96 M-145.06 M-145.93 M-182.73 M-178.4 M -172.56 M

uniQure N.V. - Ordinary Shares

uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.

新闻

Biotech Investors Are Tuning Out the MAHA Chaos

uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates

Kyverna Therapeutics: 'Strong Buy' On Additional POC Of Miv-Cel In Myasthenia Gravis

Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks.com

Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

A Unique Situation For UniQure (QURE)

瑞穗因FDA领导层变动上调uniQure股票评级

Mizuho upgrades uniQure stock rating on FDA leadership change

Avago, Lumentum among market cap stock movers on Monday

Chardan因FDA领导层变动上调uniQure股价目标